Belgium is one of the handful of EU Member States that have transposed the NIS2 Directive into national law. The Center for Cybersecurity Belgium (CCB) released Version 2.0 of its Frequently Asked Questions (FAQ) in February this year, offering updated guidance on key regulatory aspects. CCB is the Belgian national authority for cybersecurity. The FAQ […]
Our construction law partner Milan Dakić participated as a speaker at the XV Belgrade Arbitration Conference. He joined the panel Blueprints for Resolution: Navigating FIDIC Contracts and Construction Arbitration, moderated by Jovan Nikčević (Nikčević Kapor law office). The panel, which also included Chris Seppälä (Seppälä Arbitration), Sally Kottb (BakerMcKenzie/UAE), and Filip Šušulić (Karanović & Partners), […]
BDK Advokati has contributed the Serbia chapter to the 2025 edition of the Chambers Life Sciences Global Practice Guide. Authored by partner Bisera Andrijašević and associate Anja Gligorević, the chapter provides comprehensive overview of Serbia’s life sciences regulatory landscape. The Law and Practice section covers key aspects of regulatory processes and requirements throughout the […]
Definitions of crypto-assets under the Serbian Digital Assets Act (“DAA“) and MiCAR are for the most part similar: both instruments define crypto-assets as a “digital representation of value” that can be transferred electronically (the term used in MiCAR), i.e. digitally (the term used in DAA). DAA defines crypto-assets as a digital representation of value that […]
Serbia has been among the pioneers of crypto-asset market regulation. When the Digital Assets Act (Zakon o digitalnoj imovini, Official Gazette of the Republic of Serbia no. 153/2020) (DAA) was enacted, only a few countries in Europe including Switzerland, Liechtenstein, France, and Malta – had regulations in place for crypto-assets. DAA was implemented three years […]
BDK Advokati’s partner Bisera Andrijašević and associate Marija Ksenija Popović authored the Montenegro chapter of the Chambers Practice Guide on Merger Control. The Law and Practice section provides a comprehensive overview of Montenegro’s merger control framework, covering key aspects such as applicable legislation, enforcement authorities, notification requirements, authority’s approach to foreign-to-foreign transactions, joint ventures, third-party […]
On 27 February 2025, upon a request for preliminary reference, the Court of Justice of the European Union (CJEU) provided an important guidance[1] on what does and what does not constitute “advertising of medicinal products” under Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating […]
